Advertisement
Advertisement
BMRN
BioMarin Pharmaceuticals Inc
59.21
USDSponsored
+0.10
+0.17%
Jul 21, 16:00 UTC -4
Closed
After-Market
59.22
+0.01
+0.02%
BMRN Earnings Reports
Positive Surprise Ratio
BMRN beat 29 of 42 last estimates.
69%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$945.45M
/$0.70
Implied change from Q1 26 (Revenue/ EPS)
+23.39%
/+29.63%
Implied change from Q2 25 (Revenue/ EPS)
+14.54%
/-43.09%
BioMarin Pharmaceuticals Inc earnings per share and revenue
On May 04, 2026, BMRN reported earnings of 0.54 USD per share (EPS) for Q1 26, missing the estimate of 0.76 USD, resulting in a -29.47% surprise. Revenue reached 766.21 million, compared to an expected 771.12 million, with a -0.64% difference. The market reacted with a -4.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 17 analysts forecast an EPS of 0.70 USD, with revenue projected to reach 945.45 million USD, implying an increase of 29.63% EPS, and increase of 23.39% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jul 09, 2026 For Q2 26
Estimate
-$0.73
Actual
-$0.81
Surprise
-10.78%
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
What were BioMarin Pharmaceuticals Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, BioMarin Pharmaceuticals Inc reported EPS of $0.54, missing estimates by -29.47%, and revenue of $766.21M, -0.64% below expectations.
How did the market react to BioMarin Pharmaceuticals Inc's Q1 2026 earnings?
The stock price moved down -4%, changed from $55.46 before the earnings release to $53.24 the day after.
When is BioMarin Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for BioMarin Pharmaceuticals Inc's next earnings report?
Based on 17
analysts, BioMarin Pharmaceuticals Inc is expected to report EPS of $0.70 and revenue of $945.45M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement